Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.

Rose JW, Burns JB, Bjorklund J, Klein J, Watt HE, Carlson NG.

Neurology. 2007 Aug 21;69(8):785-9.

PMID:
17709711
2.

Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody.

Rose JW, Watt HE, White AT, Carlson NG.

Ann Neurol. 2004 Dec;56(6):864-7.

PMID:
15499632
3.
4.

Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion.

Rose JW, Hill KE, Watt HE, Carlson NG.

J Neuroimmunol. 2004 Apr;149(1-2):40-9.

PMID:
15020063

Supplemental Content

Support Center